Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT
Monopar Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.23M | -3.22M | -11.07M | -1.57M | -1.79M | -1.72M | -1.91M | -2.07M | -2.33M | -2.52M | -2.91M | -2.41M | -2.76M | -2.46M | -2.68M | -2.46M | -2.09M | -1.9M |
Interest Income | 780.77K | 596.85K | 149.04K | 99.34K | 73.47K | 82.17K | 98.07K | 112.26K | 128.22K | 90.49K | 12.66K | 7.7K | 417.00 | 464.00 | 525.00 | 577.00 | 12.23K | 10.7K |
Pretax Income | -2.45M | -2.63M | -10.93M | -1.3B | -1.72M | -1.64M | -1.81M | -1.95M | -2.2M | -2.44M | -2.9M | -2.4M | -2.76M | -2.46M | -2.68M | -2.46M | -2.08M | -1.88M |
Net Income | -2.45M | -2.63M | -10.93M | -1.3B | -1.72M | -1.64M | -1.81M | -1.95M | -2.2M | -2.34M | -2.88M | -2.4M | -2.76M | -2.46M | -2.68M | -2.46M | -2.08M | -1.88M |
Selling & General & Admin | 1.5M | 1.58M | 1.15M | 590.62K | 657.81K | 757.28K | 876.4K | 749.47K | 733.5K | 871.67K | 806.03K | 675.12K | 684.88K | 779.25K | 698.44K | 631.7K | 615.97K | 687.94K |
Research & Development | 1.73M | 1.64M | 9.93M | 984.28K | 1.13M | 966.11K | 1.04M | 1.32M | 1.59M | 1.65M | 2.1M | 1.73M | 2.08M | 1.68M | 1.98M | 1.83M | 1.48M | 1.21M |
Other Expenses | n/a | 558.00 | -24 | 98.00 | 194.00 | -391 | -397 | -474 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.23M | 3.22M | 11.07M | 1.57M | 1.79M | 1.72M | 1.91M | 2.07M | 2.33M | 2.52M | 2.91M | 2.41M | 2.76M | 2.46M | 2.68M | 2.46M | 2.09M | 1.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | -590.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.23M | 3.22M | 11.07M | 1.57M | 1.79M | 1.72M | 1.91M | 2.07M | 2.33M | 2.52M | 2.91M | 2.41M | 2.76M | 2.46M | 2.68M | 2.46M | 2.09M | 1.9M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.91K | n/a | n/a | -90.49K | -13.54K | n/a | -834 | -928 | -1.05K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7M | 6.91M | 37.9M | 3.52M | 3.5M | 15.98M | 14.9M | 14.12M | 13.42M | 13.11M | 12.95M | 12.76M | 12.63M | 12.6M | 12.58M | 12.58M | 12.57M | 12.14M |
Shares Outstanding (Diluted) | 7M | 6.99M | 37.9M | 3.52M | 3.5M | 15.98M | 14.9M | 14.12M | 13.42M | 13.11M | 12.95M | 12.76M | 12.63M | 12.6M | 12.58M | 12.58M | 12.57M | 12.14M |
EPS (Basic) | -0.35 | -0.38 | -0.29 | -0.37 | -0.49 | -0.1 | -0.12 | -0.14 | -0.16 | -0.18 | -0.22 | -0.19 | -0.22 | -0.19 | -0.21 | -0.2 | -0.17 | -0.16 |
EPS (Diluted) | -0.35 | -0.38 | -0.29 | -0.37 | -0.49 | -0.1 | -0.12 | -0.14 | -0.16 | -0.18 | -0.22 | -0.19 | -0.22 | -0.19 | -0.21 | -0.2 | -0.17 | -0.16 |
EBITDA | -2.45M | -3.22M | -10.5M | -1.15M | -1.36M | -1.3M | -1.81M | -1.95M | -2.33M | -2.52M | -2.91M | -2.41M | -2.76M | -2.46M | -2.68M | -2.46M | -2.09M | -1.9M |
EBIT | -2.45M | -3.22M | -10.93M | -1.3M | -1.72M | -1.64M | -1.81M | -1.95M | -2.2M | -2.44M | -2.9M | -2.4M | -2.76M | -2.46M | -2.68M | -2.46M | -2.08M | -1.88M |
Depreciation & Amortization | n/a | 3.22M | 11.07M | 1.57M | 1.79M | 1.72M | n/a | n/a | 2.33M | 2.52M | 2.91M | 2.41M | 2.76M | 2.46M | 2.68M | 2.46M | 2.09M | 1.9M |